Clinical trial
Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy
NCT00394537 · Rabin Medical Center, Other · Completed
Key facts
| NCT number | NCT00394537 |
|---|---|
| Title | Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy |
| Lead sponsor | Rabin Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bronchoscopy |
| Intervention type | Drug |
| Interventions | Labetalol 10mg iv |
| Enrollment | 72 |
| Completion | May 1, 2007 |
| First posted | Nov 1, 2006 |
| Last update posted | Jun 6, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: